Nutritional therapy to support polycystic ovary syndrome management in preconception and pregnancy programs
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with infertility, obesity, and insulin resistance. This case report describes a 21-year-old woman with PCOS, primary infertility for 3.5 years, irregular menses, and obesity (BMI 31.3 kg/m2) who was referred to a pregnancy program and received combined management including pharmacotherapy (orlistat and vitamin D3), a calorie-restricted diet, and increased physical activity. After 3 months, she lost 6 kg, with reductions in body fat and visceral fat, and improved insulin resistance; she conceived in the 4th month and later delivered a healthy, term infant. These findings suggest that integrated nutritional therapy, together with pharmacological treatment and lifestyle modification, may support weight loss, improve metabolic parameters, and enhance pregnancy outcomes in women with PCOS, though controlled studies are needed to confirm efficacy and define optimal interventions.
Downloads
License
© 2025 Author(s). Published by Sains Medika: Jurnal Kedokteran dan Kesehatan. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Abedini, M., Ghaedi, E., Hadi, A., Mohammadi, H., & Amani, R. (2019). Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis. Journal of Trace Elements in Medicine and Biology, 52 (March): 216–221. https://doi.org/10.1016/j.jtemb.2019.01.002
Bahadur, A., Yadav, A., Mundhra, R., Chawla, L., Naithani, M., & Chaturvedi, J. (2022). Effect of two different doses of vitamin D supplementation on clinical, metabolic, and hormonal profiles of patients with polycystic ovary syndrome (PCOS) with insulin resistance: A randomized controlled trial. Journal of South Asian Federation of Obstetrics and Gynaecology, 14(3), 307–312. https://doi.org/10.5005/jp-journals-10006-2052
Barber, T. M., Kabisch, S., Pfeil, A. F. H., & Weickert, M. O. (2020). Nutrients and weight management in obesity. Nutrients, 12(3209): 1–17. https://doi.org/10.3390/nu1203209
De, K. (2017). Waist circumference, waist–hip ratio and body mass index in assessing nutritional status and central obesity of adolescents. Global Journal of Archaeology & Anthropology, 1(1), 4–7. https://doi.org/10.19080/GJAA.2017.01.555552
Faghfoori, Z., Fazelian, S., Shadnoush, M., & Goodarzi, R. (2017). Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes & Metabolic Syndrome: Clinical Research and Reviews, 11(Suppl 1): S429–S432. https://doi.org/10.1016/j.dsx.2017.03.030
Farhood, G., & Iqbal. (2017). Assessment of serum zinc level in patients with polycystic ovary syndrome. Iraqi Journal of Medical Sciences, 15(1), 39–47. https://doi.org/10.22578/ijms.15.1.6
Farshchi, H., Rane, A., Love, A., & Kennedy, R. L. (2007). Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management. Journal of Obstetrics and Gynaecology, 27(8): 762–773. https://doi.org/10.1080/01443610701667338
Firouzabadi, R., Dehghani, A., Aflatoonian, A., Modarresi, S., Sekhavat, L., & Mohammad-Taheri, S. (2012). Therapeutic effects of calcium and vitamin D supplementation in women with PCOS. Complementary Therapies in Clinical Practice, 18(2): 85–88. https://doi.org/10.1016/j.ctcp.2012.01.005
Grudén, S., Forslund, A., Alderborn, G., Söderhäll, A., Hellström, P. M., & Holmbäck, U. (2021). Safety of a novel weight loss combination product containing orlistat and acarbose. Clinical Pharmacology in Drug Development, 10(10), 1242–1247. https://doi.org/10.1002/cpdd.920
Günalan, E., Yaba, A., & Yılmaz, B. (2018). The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review. Journal of the Turkish-German Gynecological Association, 19(4): 220–232. https://doi.org/10.4274/jtgga.2018.0077
Hita, I. P. A. D. (2020). Efektivitas metode latihan aerobik dan anaerobik untuk menurunkan tingkat overweight dan obesitas. Jurnal Penjakora, 7(2): 135–143. https://doi.org/10.23887/penjakora.v7i2.27375
Kirschner, M. A. (2008). Management of obesity. Current Respiratory Medicine Reviews, 4(2): 122–130. https://doi.org/10.2174/157339808784222786
Nasiadek, M., Stragierowicz, J., Klimczak, M., & Kilanowicz, A. (2020). The role of zinc in selected female reproductive system disorders. Nutrients, 12(2464): 1-21. https://doi.org/10.3390/nu12082464
Ngo, D. T., Chan, W. P., Rajendran, S., Heresztyn, T., Amarasekera, A., Sverdlov, A. L., et al. (2011). Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide, 25(3): 326–330. https://doi.org/10.1016/j.niox.2011.06.007
Papavasiliou, K., & Papakonstantinou, E. (2017). Nutritional support and dietary interventions for women with polycystic ovary syndrome. Nutrition and Dietary Supplements, 9: 63–85. https://doi.org/10.2147/NDS.S119738
Menteri Kesehatan Republik Indonesia. (2019). Peraturan Menteri Kesehatan Republik Indonesia Nomor 28 Tahun 2019 tentang Angka Kecukupan Gizi yang Dianjurkan untuk Masyarakat Indonesia. Jakarta: Menteri Kesehatan Republik Indonesia.
Pinho, C. P. S., Diniz, A. da S., Arruda, I. K. G., Leite, A. P. D. L., Petribu, M. M. V., & Rodrigues, I. G. (2018). Waist circumference measurement sites and their association with visceral and subcutaneous fat and cardiometabolic abnormalities. Archives of Endocrinology and Metabolism, 62(4): 416–423. https://doi.org/10.20945/2359-3997000000055
Qi, X. (2018). Review of the clinical effect of orlistat. IOP Conference Series: Materials Science and Engineering, 301(012063). https://doi.org/10.1088/1757-899X/301/1/012063
Rahimi-Ardabili, H., Pourghassem Gargari, B., & Farzadi, L. (2013). Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. Journal of Endocrinological Investigation, 36(1): 28–32. https://doi.org/10.1007/BF03346753
Rolland, A. L., & Dewailly, D. (2015). Relevance of myo-inositol in polycystic ovary syndrome. Médecine Thérapeutique Médecine de la Reproduction et Gynécologie Endocrinologie, 17(3): 186–192. https://doi.org/10.1684/mte.2015.0560
Shojaeian, Z., Sadeghi, R., & Roudsari, R. L. (2019). Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles, and follicular responses in women with polycystic ovary syndrome: A systematic review and meta-analysis. Caspian Journal of Internal Medicine, 10(4): 359–369. https://doi.org/10.22088/cjim.10.4.359
Sofa, I. M. (2018). Kejadian obesitas, obesitas sentral, dan kelebihan lemak viseral pada lansia wanita. Amerta Nutrition, 2(3): 228–236. https://doi.org/10.20473/amnt.v2i3.2018.228-236
Soufizadeh, N., Farhadifar, F., Seyedoshohadaei, F., Rezaei, M., Rasouli, M. A., & Ebrahimpour, K. (2021). The effect of inofolic supplementation on women with polycystic ovarian syndrome (PCOS): A randomized clinical trial study. Italian Journal of Gynaecology & Obstetrics, 33(4), 256–262. https://doi.org/10.36129/jog.33.04.06
Suryani Putri, R., Djuari, L., & Prajitno, S. (2022). Central obesity as a risk factor of hypertension in elderly at Banjararum Village, Singosari, Malang. International Journal of Research Publications, 94(1), 402–409. https://doi.org/10.47119/ijrp100941220222843
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinology, 77(3): 343–350. https://doi.org/10.1111/j.1365-2265.2012.04351.x
Wechselberg, K. (1967). [Obesity and weight loss in childhood]. Deutsche Zentralblatt für Krankenpflege, 11(8): 339–341. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5182945
World Health Organization. (2000). Redefining Obesity and Its Treatment. International Association for the Study of Obesity.
